CHROMADEX CORP
CHROMADEX CORP
Share · US1710774076 · CDXC · A2AG5N (XNCM)
Overview Financial Indicators
13,35 USD
2,61 % 0,34 USD
NASDAQ CAPITAL MARKET (XNAS) · Current prices and charts at MoneyPeak
09.06.2025 18:28

Current Prices from CHROMADEX CORP

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
NAGE
USD
09.06.2025 18:28
13,35 USD
12,95 USD
+3,09 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
2,61 % 12,75 % 44,48 % 73,38 % 98,66 % 317,19 % 188,96 %

Company Profile for CHROMADEX CORP Share

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

Company Data

Name CHROMADEX CORP
Company ChromaDex Corporation
Symbol CDXC
Website https://www.chromadex.com
Primary Exchange XNCM NASDAQ CAPITAL MARKET
WKN A2AG5N
ISIN US1710774076
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Frank Louis Jaksch Jr.
Market Capitalization 612 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 10900 Wilshire Boulevard, 90024 Los Angeles
IPO Date 2008-06-25

Stock Splits

Date Split
13.04.2016 1:3

ID Changes

Date From To
19.03.2025 CDXC NAGE

Ticker Symbols

Name Symbol
Frankfurt OCD1.F
NASDAQ CDXC
NASDAQ NAGE

More Shares

Investors who CHROMADEX CORP hold also have the following shares in their portfolio:
ALPHAWAVE IP GROUP
ALPHAWAVE IP GROUP Share
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BASF SE OPA.17/23 OO
BASF SE OPA.17/23 OO Bond
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DEXCO INC
DEXCO INC Share
GENERAL ELECT. 03/40 MTN
GENERAL ELECT. 03/40 MTN Bond
INTEL CORP
INTEL CORP Share
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NETFLIX INC
NETFLIX INC Share
NEWMARK GROUP INC - CLASS A
NEWMARK GROUP INC - CLASS A Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025